ZFP THERAPEUTIC Trademark

Trademark Overview

On Monday, September 14, 2009, a trademark application was filed for ZFP THERAPEUTIC with the United States Patent and Trademark Office. The USPTO has given the ZFP THERAPEUTIC trademark a serial number of 77826199. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 5, 2021. This trademark is owned by Sangamo Biosciences, Inc.. The ZFP THERAPEUTIC trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research and development, clinical testing, and consultation related thereto, all in the field of pharmaceutical preparations and drugs
zfp therapeutic

General Information

Serial Number77826199
Word MarkZFP THERAPEUTIC
Filing DateMonday, September 14, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 5, 2021
Registration Number3829806
Registration DateTuesday, August 3, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical and scientific research and development, clinical testing, and consultation related thereto, all in the field of pharmaceutical preparations and drugs

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 5, 2021
Primary Code042
First Use Anywhere DateTuesday, February 15, 2005
First Use In Commerce DateTuesday, February 15, 2005

Trademark Owner History

Party NameSANGAMO THERAPEUTICS, LNC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressRICHMOND, CA 94804
Party NameSangamo Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRichmond, CA 94804
Party NameSangamo Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRichmond, CA 94804

Trademark Events

Event DateEvent Description
Friday, March 5, 2021CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, August 3, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, May 24, 2017ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, April 19, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, August 5, 2016NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Friday, August 5, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED
Friday, August 5, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, July 21, 2016TEAS SECTION 8 RECEIVED
Monday, August 3, 2015COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, August 3, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 3, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 3, 2010REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, June 29, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 29, 2010ASSIGNED TO LIE
Wednesday, June 16, 2010NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, June 15, 2010APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Tuesday, June 15, 2010USE AMENDMENT ACCEPTED
Tuesday, June 15, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 14, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 14, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 15, 2010AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, June 15, 2010USE AMENDMENT FILED
Monday, June 14, 2010TEAS AMENDMENT OF USE RECEIVED
Monday, December 14, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 14, 2009NON-FINAL ACTION E-MAILED
Monday, December 14, 2009NON-FINAL ACTION WRITTEN
Sunday, December 13, 2009ASSIGNED TO EXAMINER
Thursday, September 17, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 17, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutic field thereto pharmaceutical preparations drugs related consultation research scientific development